Gilead Sciences Inc. (NASDAQ:GILD) price target has been increased by Deutsche Bank due to increased confidence regarding the company’s Hepatitis C virus’ success after this weekend’s data. The firm is convinced that Gilead has the best in class HCV drug, and it has decided to reiterates its Buy rating on the stock.
Tornier N.V. (NASDAQ:TRNX): According to Piper Jaffray, it would be a buyer of Tornier shares on any weakness after CEO Doug Kohrs retired and resigned. Piper does not view the resignation as having any connections to accounting or conduct improprieties, it maintains its Overweight rating on the stock.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
W.W. Grainger, Inc. (NYSE:GWW): According to Citigroup’s purchasing manager survey, few managers currently are transitioning purchasing away from traditional distributors like Grainger to AmazonSupply. However, Citi still views Amazon (NASDAQ:AMZN) as a longer term threat to Grainger. The firm maintains its Sell rating on the stock.
Annaly Capital Management, Inc. (NYSE:NLY) possible acquisition of CreXus (NYSE:CXS) is viewed by FBR Capital as an admittance by Annaly that its agency MBS model is unable to function in the current environment. FBR keeps its Underperform rating and reduced its price target to $13.50 on the stock.
QUALCOMM Incorporated (NASDAQ:QCOM): Nomura thinks that the market is underestimating Qualcomm’s licensing growth driven emerging markets 3g subscriber penetration. The firm is under the impression that affordable smartphones globally along with new features will be positive for replacement rates. Shares have a Buy rating.
Don’t Miss: Are These Top Tech Companies Too Big to Fail?